Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Wolf

Showing results (281-290 of 384) with videos related to

Pageof 39
Sort By:
Scientific Reports|January 18, 2017
Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular DegenerationMartin S Zinkernagel, Denise C Zysset-Burri, Irene Keller, et al.
Annals of Surgical Oncology|February 4, 2025
Intraoperative Endoluminal Pyloromyotomy Versus Stretching of the Pylorus for the Reduction of Delayed Gastric Emptying After Pylorus-Preserving Partial Pancreatoduodenectomy: A Blinded Randomized Controlled Trial (PORRIDGE Study; DRKS00013503)Matthias C Schrempf, Matthias Anthuber, Johann Spatz, et al.
The British Journal of Ophthalmology|May 14, 2026
Assessing intergrader variability in incomplete outer retinal atrophy (iRORA) gradingLorenzo Ferro Desideri, Davide Scandella, Rodrigo Anguita, et al.
Ophthalmology|December 12, 2013
RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopiaSebastian Wolf, Vilma Jurate Balciuniene, Guna Laganovska, et al.
JAMA Ophthalmology|April 23, 2026
Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical TrialSebastian Wolf, Youxin Chen, Xiaorong Li, et al.
Retinal Cases & Brief Reports|November 6, 2018
RANIBIZUMAB 0.5 MG TREATMENT IN ADOLESCENTS WITH CHOROIDAL NEOVASCULARIZATION: SUBGROUP ANALYSIS DATA FROM THE MINERVA STUDYPhilip G Hykin, Giovanni Staurenghi, Peter Wiedemann, et al.
Investigative Ophthalmology & Visual Science|November 17, 2015
Time-Resolved Ultra-High Resolution Optical Coherence Tomography for Real-Time Monitoring of Selective Retina TherapyPatrick Steiner, Andreas Ebneter, Lieselotte Erika Berger, et al.
BMC Plant Biology|December 14, 2019
The in vivo impact of MsLAC1, a Miscanthus laccase isoform, on lignification and lignin composition contrasts with its in vitro substrate preferenceFeng He, Katja Machemer-Noonan, Philippe Golfier, et al.
Acta Ophthalmologica|May 6, 2025
Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trialDamian Jaggi, Lieselotte E Berger, Sandrine Zweifel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2018
BRI1 controls vascular cell fate in the <i>Arabidopsis</i> root through RLP44 and phytosulfokine signalingEleonore Holzwart, Apolonio Ignacio Huerta, Nina Glöckner, et al.
Pageof 39

Showing results (281-290 of 384) with videos related to

Sort By:
Pageof 39
Scientific Reports|January 18, 2017
Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular DegenerationMartin S Zinkernagel, Denise C Zysset-Burri, Irene Keller, et al.
Annals of Surgical Oncology|February 4, 2025
Intraoperative Endoluminal Pyloromyotomy Versus Stretching of the Pylorus for the Reduction of Delayed Gastric Emptying After Pylorus-Preserving Partial Pancreatoduodenectomy: A Blinded Randomized Controlled Trial (PORRIDGE Study; DRKS00013503)Matthias C Schrempf, Matthias Anthuber, Johann Spatz, et al.
The British Journal of Ophthalmology|May 14, 2026
Assessing intergrader variability in incomplete outer retinal atrophy (iRORA) gradingLorenzo Ferro Desideri, Davide Scandella, Rodrigo Anguita, et al.
Ophthalmology|December 12, 2013
RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopiaSebastian Wolf, Vilma Jurate Balciuniene, Guna Laganovska, et al.
JAMA Ophthalmology|April 23, 2026
Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical TrialSebastian Wolf, Youxin Chen, Xiaorong Li, et al.
Retinal Cases & Brief Reports|November 6, 2018
RANIBIZUMAB 0.5 MG TREATMENT IN ADOLESCENTS WITH CHOROIDAL NEOVASCULARIZATION: SUBGROUP ANALYSIS DATA FROM THE MINERVA STUDYPhilip G Hykin, Giovanni Staurenghi, Peter Wiedemann, et al.
Investigative Ophthalmology & Visual Science|November 17, 2015
Time-Resolved Ultra-High Resolution Optical Coherence Tomography for Real-Time Monitoring of Selective Retina TherapyPatrick Steiner, Andreas Ebneter, Lieselotte Erika Berger, et al.
BMC Plant Biology|December 14, 2019
The in vivo impact of MsLAC1, a Miscanthus laccase isoform, on lignification and lignin composition contrasts with its in vitro substrate preferenceFeng He, Katja Machemer-Noonan, Philippe Golfier, et al.
Acta Ophthalmologica|May 6, 2025
Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trialDamian Jaggi, Lieselotte E Berger, Sandrine Zweifel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2018
BRI1 controls vascular cell fate in the <i>Arabidopsis</i> root through RLP44 and phytosulfokine signalingEleonore Holzwart, Apolonio Ignacio Huerta, Nina Glöckner, et al.
Pageof 39